Vigano Paul R
SEC Form 4 history across 1 companies, 9 transactions and 2 filings.
Available history · Jun 03, 2026 – Aug 21, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
AVAHAveanna Healthcare Holdings, Inc. | Vigano Paul R10% | S · saleSEC filing ↗ | -$25.8MView disclosure → | |
AVAHAveanna Healthcare Holdings, Inc. | Vigano Paul R10% | S · saleSEC filing ↗ | -$2.18MView disclosure → | |
AVAHAveanna Healthcare Holdings, Inc. | Vigano Paul R10% | S · saleSEC filing ↗ | -$16.3MView disclosure → | |
AVAHAveanna Healthcare Holdings, Inc. | Vigano Paul R10% | S · saleSEC filing ↗ | -$20.8MView disclosure → | |
AVAHAveanna Healthcare Holdings, Inc. | Vigano Paul R10% | S · saleSEC filing ↗ | -$11.0MView disclosure → | |
AVAHAveanna Healthcare Holdings, Inc. | Vigano Paul R10% | S · saleSEC filing ↗ | -$116MView disclosure → | |
AVAHAveanna Healthcare Holdings, Inc. | Vigano Paul R10% | S · saleSEC filing ↗ | -$685kView disclosure → | |
AVAHAveanna Healthcare Holdings, Inc. | Vigano Paul R10% | S · saleSEC filing ↗ | -$6.53MView disclosure → | |
AVAHAveanna Healthcare Holdings, Inc. | Vigano Paul R10% | S · saleSEC filing ↗ | -$36.4MView disclosure → |
Latest Form 4 facts
Quick context from source filings
sale at Aveanna Healthcare Holdings, Inc. on Aug 21, 2026 valued at $25,875,000.
Review SEC filingNo open-market insider purchase is available.
sale at Aveanna Healthcare Holdings, Inc. on Aug 21, 2026 valued at $25,875,000.
Review SEC filingMonthly open-market activity
Last 2 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| Jun 2026 | 0 | 3 | $0.00 | $43,680,000.00 | -$43,680,000.00 |
| Aug 2026 | 0 | 6 | $0.00 | $192,625,023.00 | -$192,625,023.00 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
2 observations · Aug 20, 2026 – Aug 21, 2026. Window ends at the latest available report, not today.
View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Aug 20, 2026 | 14,565,892 | Aug 24, 2026 | View transaction |
| Aug 21, 2026 | 12,315,892 | Aug 24, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Vigano Paul R Insider Activity FAQ
SEC Form 4 context
Who is Vigano Paul R?
Vigano Paul R is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001239606.
Which companies has Vigano Paul R reported transactions for?
Aveanna Healthcare Holdings, Inc.
When was Vigano Paul R's latest insider buy?
No open-market insider purchase is available for this period.
When was Vigano Paul R's latest insider sale?
sale at Aveanna Healthcare Holdings, Inc. on Aug 21, 2026 valued at $25,875,000.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.